NewEdge Advisors LLC Has $19.68 Million Position in Intuitive Surgical, Inc. $ISRG

NewEdge Advisors LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 65.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 42,683 shares of the medical equipment provider’s stock after acquiring an additional 16,847 shares during the period. NewEdge Advisors LLC’s holdings in Intuitive Surgical were worth $19,676,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC grew its position in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after buying an additional 731 shares during the last quarter. Sivia Capital Partners LLC increased its position in shares of Intuitive Surgical by 3.8% during the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock worth $504,000 after buying an additional 34 shares during the period. Schnieders Capital Management LLC. increased its position in shares of Intuitive Surgical by 38.0% during the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock worth $529,000 after buying an additional 268 shares during the period. Osterweis Capital Management Inc. bought a new position in Intuitive Surgical during the second quarter worth $200,000. Finally, Main Street Financial Solutions LLC boosted its position in Intuitive Surgical by 92.4% during the second quarter. Main Street Financial Solutions LLC now owns 2,929 shares of the medical equipment provider’s stock valued at $1,592,000 after acquiring an additional 1,407 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Intuitive Surgical Stock Performance

Shares of Intuitive Surgical stock opened at $378.81 on Friday. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The stock has a 50 day moving average price of $392.87 and a two-hundred day moving average price of $445.78. The stock has a market capitalization of $133.83 billion, a PE ratio of 43.39, a price-to-earnings-growth ratio of 2.70 and a beta of 1.46.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The firm had revenue of $2.89 billion during the quarter, compared to the consensus estimate of $2.83 billion. During the same quarter in the previous year, the company posted $1.81 earnings per share. The company’s quarterly revenue was up 18.4% on a year-over-year basis. Research analysts forecast that Intuitive Surgical, Inc. will post 8.87 EPS for the current year.

Analyst Ratings Changes

Several brokerages recently commented on ISRG. Piper Sandler set a $357.44 target price on Intuitive Surgical in a research report on Monday, July 27th. BTIG Research dropped their price target on Intuitive Surgical from $512.00 to $469.00 and set a “buy” rating on the stock in a research note on Friday, July 17th. BNP Paribas Exane upgraded Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Royal Bank Of Canada lowered their price objective on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a research note on Monday, July 13th. Finally, Evercore set a $430.00 target price on shares of Intuitive Surgical in a research note on Monday, July 6th. Twenty equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $509.02.

Insider Activity at Intuitive Surgical

In other news, SVP Iman Jeddi sold 5,625 shares of the company’s stock in a transaction on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the sale, the senior vice president owned 6,463 shares in the company, valued at $2,718,014.65. This represents a 46.53% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $424.14, for a total transaction of $169,656.00. Following the completion of the sale, the executive vice president owned 5,720 shares of the company’s stock, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 6,634 shares of company stock worth $2,796,795. 0.60% of the stock is owned by insiders.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.